Podiatric Medicine

Summary

The bill updates podiatry licensing by requiring specific continuing‑education for doctors who prescribe controlled substances and creates rules for using cellular or tissue‑based products that are not FDA‑approved. Podiatrists may now employ these products for tendon, ligament, wound or pain procedures, but must meet strict facility standards, display a warning notice in ads, and obtain detailed patient consent. The changes aim to promote medical innovation while ensuring patient safety and ethical sourcing.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share